JUBILANT PHARMOVA long consolidation BO & retest done
The stock has shown a breakout, and the retest has been completed. It looks poised to rise significantly, with a stop-loss set at the strong monthly candle close below 780.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.